Medizone Intl. (fka MZEIQ)

[BenK]

After a few days of hearing various perspectives on the AGM, both from the attendees and those of us who were waiting for their reports, I've come to realize something. A lot of our feelings of being let down and frustrated are self-inflicted wounds.

We got all excited leading up to the meeting, assuming - understandably -that there will be an opportunity for free and open discussion, questions and clarifications, and all the black clouds that shrouded Medizone for years will miraculously disappear. All the issues that we've been frustrated about for years, since the last AGM seven years ago, will be dealt with.

This wasn't realistic, because we forgot one basic fact of life (and I include myself in this mistake): Ed really doesn't understand the power and value of communication, and it just wasn't going to happen.

So the expectations were dashed, and we end up frustrated, feeling mistreated, etc.

But the truth is, nothing has changed! A wasted opportunity for communication, and the feeling that not enough respect was shown to shareholders who made the effort to show up in SLC, doesn't change the basic facts: We have a great product, with EPA approval, tests are lined up in a month, and the process is moving ahead.

To say, as someone did, that Ed hasn't done anything for four years, is just silly. Do some claim he should have done it better, and in half the time? That I can understand. But don't tell me that nothing was accomplished. That's unfair and off the mark.

There is way too much focus on either glorifying or demonizing management. Both sides of this argument need to take a deep breath, step back a little, and recognize that despite all the stumbling that took place over the years, we are where we need to be.

As I wrote earlier, experienced talent will be coming in at some point to make the transition to sales, and formulate the plans for the next stage.

I heard from someone at the AGM that at one point Ed said that "we have someone on the Board who sold a company for $3.5 billion!", referring to Esposito, and implying that that same expertise will be used with Medizone.

Let's allow things to move forward, without letting the disappointment of unfulfilled over-expectations throw us into an artificial crisis.